Order Article Reprints

Bao R, Qin J, Zhang R, Xu Z, Liu J, Shen J, Zhang S, Zhang Y, Zhu H, Huang C, et al. Claudin 18.2 Expression and Outcomes of First-Line Chemoimmunotherapy in HER2-Negative Gastric or Gastroesophageal Junction Cancer: A Single-Center Retrospective Study. Current Oncology. 2026; 33(8):460. https://doi.org/10.3390/curroncol33080460

Bao, Run, Jing Qin, Rong Zhang, Zhuo Xu, Jiahao Liu, Jiaofeng Shen, Shunji Zhang, Yusong Zhang, Hong Zhu, Chunyan Huang, and et al. 2026. "Claudin 18.2 Expression and Outcomes of First-Line Chemoimmunotherapy in HER2-Negative Gastric or Gastroesophageal Junction Cancer: A Single-Center Retrospective Study" Current Oncology 33, no. 8: 460. https://doi.org/10.3390/curroncol33080460

Bao, R., Qin, J., Zhang, R., Xu, Z., Liu, J., Shen, J., Zhang, S., Zhang, Y., Zhu, H., Huang, C., Lu, Y., Liu, T., & Pu, W. (2026). Claudin 18.2 Expression and Outcomes of First-Line Chemoimmunotherapy in HER2-Negative Gastric or Gastroesophageal Junction Cancer: A Single-Center Retrospective Study. Current Oncology, 33(8), 460. https://doi.org/10.3390/curroncol33080460